tiprankstipranks
Hikma Pharmaceuticals PLC (HKMPY)
OTHER OTC:HKMPY
US Market
HKMPY
Hikma Pharmaceuticals
RESEARCH TOOLSreports
Want to see HKMPY full AI Analyst Report?

Hikma Pharmaceuticals (HKMPY) Income Statement

44 Followers

Hikma Pharmaceuticals Income Statement

Last quarter (Q4 2025), Hikma Pharmaceuticals's total revenue was $1.68B, an increase of 17.28% from the same quarter last year. In Q4, Hikma Pharmaceuticals's net income was $163.39M. See Hikma Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 3.36B$ 3.13B$ 2.88B$ 2.52B$ 2.55B
Gross Profit
$ 1.34B$ 1.42B$ 1.41B$ 1.24B$ 1.30B
Operating Expenses
$ 718.68M$ 803.00M$ 1.04B$ 956.00M$ 719.00M
Depreciation and Amortization
$ 212.50M$ 197.00M$ 191.00M$ 190.00M$ 167.00M
EBITDA
$ 837.95M$ 727.00M$ 559.00M$ 688.00M$ 766.00M
Operating Income
$ 625.46M$ 612.00M$ 367.00M$ 282.00M$ 582.00M
Other Income/Expenses
$ -105.25M$ -158.00M$ -86.00M$ -49.00M$ -39.00M
Pretax Income
$ 520.21M$ 454.00M$ 281.00M$ 233.00M$ 543.00M
Net Income
$ 402.94M$ 359.00M$ 190.00M$ 188.00M$ 421.00M
Per Share Metrics
Basic EPS
$ 3.66$ 3.24$ 1.70$ 1.68$ 3.64
Diluted EPS
$ 3.62$ 3.22$ 1.72$ 1.68$ 3.62
Weighted Average Shares Outstanding
 110.29M 110.67M 111.18M 111.86M 115.50M
Weighted Average Shares Outstanding (Diluted)
 111.34M 111.75M 111.18M 112.50M 116.50M
Currency in USD

Hikma Pharmaceuticals Earnings and Revenue History